Re: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes: Editorial comment

Samir S. Taneja

doi:10.1016/j.juro.2014.03.063

Re: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes: Editorial comment

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1783-1784
Number of pages	2
Journal	Journal of Urology
Volume	191
Issue number	6
DOIs	https://doi.org/10.1016/j.juro.2014.03.063
State	Published - 2014

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2014.03.063

Cite this

@article{31780d8a5adf4232abdd8d7d610ade39,

title = "Re: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes: Editorial comment",

author = "Taneja, {Samir S.}",

year = "2014",

doi = "10.1016/j.juro.2014.03.063",

language = "English (US)",

volume = "191",

pages = "1783--1784",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Re

T2 - Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes: Editorial comment

AU - Taneja, Samir S.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84908205515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908205515&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2014.03.063

DO - 10.1016/j.juro.2014.03.063

M3 - Comment/debate

C2 - 25280280

AN - SCOPUS:84908205515

SN - 0022-5347

VL - 191

SP - 1783

EP - 1784

JO - Journal of Urology

JF - Journal of Urology

IS - 6

ER -

Re: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes: Editorial comment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this